BioSpace News Archive

Orasis Pharmaceuticals today announced that the Phase 3 NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of CSF-1, its novel eye drop candidate, met their primary and key secondary endpoints.

ico metrix announced the recent release of a Medtech Innovation Briefing (MIB) [ MIB291 ] from the internationally renowned NICE for the CE markers and FDA cleared ico brain MRI measures in Multiple Sclerosis (MS).

Albany NY, United States: Imaging in dermatology has evolved exponentially from its introduction as an analog device with limited resolution eyepiece and single illumination to a digital device with magnified resolution and multiple illumination options.

The global refractory angina market is expected to expand at a higher CAGR during the forecast period of 2019 to 2032.

MaaT Pharma announced on March 28th, 2022, the inclusion of the first patient in a pivotal Phase 3 clinical trial, potentially the last step of clinical development before marketing authorization, evaluating MaaT013 for the treatment of acute gastrointestinal Graft-versus-Host Disease, a serious complication following stem cell transplantation.

[21-April-2022] Figures for the first quarter of 2022: Sales revenue up 25.4 percent in constant currencies, underlying EBITDA up 32.4 percent, underlying EBITDA margin 34.1 percent Healthy demand situation; normalization of pandemic-related effects and development of order intake, as expected; extensive investment program on schedule Positioning of both divisions strengthened by one acquisiti

Active Biotech entered into global patent license agreement with Oncode Institute for tasquinimod in myelofibrosis (Feb 9)

DaVita Inc., announced that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time.

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to March 2022.

It takes years of diligent training as well as a trusting relationship between horse and rider to reach their full potential as a team.